By Mill Chart
Last update: May 9, 2024
GILEAD SCIENCES INC (NASDAQ:GILD) was identified as a stock worth exploring by dividend investors by our stock screener. NASDAQ:GILD scores well on profitability, solvency and liquidity. At the same time it seems to pay a decent dividend. We'll explore this a bit deeper below.
ChartMill assigns a Dividend Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing various dividend elements, such as yield, historical performance, dividend growth, and sustainability. NASDAQ:GILD has been awarded a 7 for its dividend quality:
ChartMill utilizes a Health Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of liquidity and solvency ratios, both in absolute terms and in comparison to industry peers. NASDAQ:GILD has earned a 5 out of 10:
Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:GILD has achieved a 7:
Every day, new Best Dividend stocks can be found on ChartMill in our Best Dividend screener.
For an up to date full fundamental analysis you can check the fundamental report of GILD
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
GILEAD SCIENCES INC
NASDAQ:GILD (5/17/2024, 7:01:44 PM)
After market: 67.58 -0.14 (-0.21%)67.72
-0.14 (-0.21%)
CHICAGO - May 18, 2024 - PRLog -- The Pulse of Perseverance alongside Gilead is proud to announce the launch of the P3 mobile app, a pioneering platform unveiled at our signature benefit event on May 16, now available on the app store. Designed to transform the landscape of mentorship, the P3 app connects students from underprivileged backgrounds with mentors in underrepresented fields, fostering a supportive community and opening doors to internships and career opportunities.Amidst the backdrop of systemic barriers that often hinder the academic and professional aspirations of Black children, the P3 app stands as a beacon of hope and opportunity. It not only bridges the gap in resource access but also challenges the status quo by providing a direct funnel to success in advanced fields where youth from socioeconomically disadvantaged areas are vastly underrepresented.Features of the P3 App:
Penny stocks to buy understandably offers many enticing attributes, not least of which is the potential for tremendous returns.
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot.
Why GILEAD SCIENCES INC (NASDAQ:GILD) is a Top Pick for Dividend Investors.
If you want your shot at significant upside, speculate on these stocks near 52-week lows that can prove the critics wrong.